These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 598422)

  • 1. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
    Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
    Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
    Dollery CT; Reid JL
    Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
    Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
    Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
    Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
    Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats.
    Naruse T; Ishii R; Tagawa T
    Jpn J Pharmacol; 1995 Apr; 67(4):407-410. PubMed ID: 7650877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent resistance to hypotensive effect of clonidine.
    Wing LM; Reid JL; Davies DS; Dargie HJ; Dollery CT
    Br Med J; 1977 Jan; 1(6054):136-8. PubMed ID: 832037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.
    Frisk-Holmberg M; Paalzow L; Wibell L
    Eur J Clin Pharmacol; 1984; 26(3):309-13. PubMed ID: 6734692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
    Anavekar SN; Jarrott B; Toscano M; Louis WJ
    Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and side-effects of clonidine.
    Keränen A; Nykänen S; Taskinen J
    Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation and plasma concentration of clonidine hydrochloride for pre-anesthetic medication in pediatric surgery.
    Sumiya K; Homma M; Watanabe M; Baba Y; Inomata S; Kihara S; Toyooka H; Kohda Y
    Biol Pharm Bull; 2003 Apr; 26(4):421-3. PubMed ID: 12673018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sliding intravenous dose schedule for clonidine in hypertensive patients.
    Velasco M; Gallardo E; Plaja J; Guevara J
    Clin Pharmacol Ther; 1976 Jul; 20(1):31-5. PubMed ID: 776490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of clonidine: relationship between plasma concentration and pharmacological effect in animals and man.
    Reid JL; Barber ND; Davies DS
    Arch Int Pharmacodyn Ther; 1980; Suppl():11-6. PubMed ID: 7416873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clonidine levels in hypertension.
    Velasquez MT; Rho J; Maronde RF; Barr J
    Clin Pharmacol Ther; 1983 Sep; 34(3):341-6. PubMed ID: 6883910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.